Tag: price of drugs

Posted on October 6, 2015

Economic value of the utility-expansion for new cancer drugs approved in Canada from 2004 to 2014.

Summary Authors: Kimberley Tran (M.A.); Brett J Skinner (Ph.D.) In the Canadian health technology assessment (HTA) process, drugs are evaluated for clinical and cost-effectiveness following Health Canada marketing approval. Usually, each drug indication is evaluated by HTA bodies individually in line with the specific indication granted by Health Canada. However, when a cancer drug is […] Read More